Fenoldopam hydrobromide (SKF 82526) is a synthetic benzazepine analog acting as a selective D1 receptor partial agonist. It was approved by the Food and Drug Administration (FDA) in September 1997 as an antihypertensive agent. Since fenoldopam is the only intravenous agent that improves renal perfusion, in theory it could be beneficial in hypertensive patients with concomitant renal insufficiency.

纯度：≥98%

CAS：67287-54-1